Corcept Therapeutics
CORT
#2462
Rank
S$8.98 B
Marketcap
S$82.07
Share price
-2.09%
Change (1 day)
-17.42%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): S$0.14 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are S$0.96 Billion. In 2025 the company made an earning of S$57.78 Million a decrease over its 2024 earnings that were of S$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.14 B145.91%
2025 S$57.78 M-67.29%
2024 S$0.17 B27.66%
2023 S$0.13 B-4.75%
2022 S$0.14 B-9.51%
2021 S$0.16 B-2.91%
2020 S$0.16 B14.87%
2019 S$0.14 B24.71%
2018 S$0.11 B69.32%
2017 S$68.18 M419.26%
2016 S$13.13 M-395.64%
2015 -S$4.45 Million-87.53%
2014 -S$35.63 Million-33.44%
2013 -S$53.53 Million
2011 -S$41.71 Million17.84%
2010 -S$35.4 Million35.5%
2009 -S$26.13 Million2.84%
2008 -S$25.4 Million60.81%
2007 -S$15.8 Million-52.14%
2006 -S$33.01 Million20.91%
2005 -S$27.3 Million31.87%
2004 -S$20.7 Million60.54%
2003 -S$12.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.15 B 16,779.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$16.30 B 11,299.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$8.98 B 6,182.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$44.85 B 31,249.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$8.67 B 5,961.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.61 B 10,117.29%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-S$62.77 Million-143.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.10 B-28.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$56.32 M-60.63%๐Ÿ‡บ๐Ÿ‡ธ USA